Home / Compare / Orforglipron vs Semaglutide
Orforglipron vs Semaglutide
Orforglipron vs Semaglutide: how they work, doses used, FDA status and trial weight loss (about 12% vs 14.9%), with sources.
| Orforglipron | Semaglutide | |
|---|---|---|
| Works on | GLP-1 only (small molecule, not a peptide) | GLP-1 only |
| How it is taken | Tablet, once daily (Foundayo) | Injection weekly (Ozempic, Wegovy) or daily tablet |
| US status | FDA-approved April 2026 (weight) | FDA-approved (2017 diabetes, 2021 weight) |
| Highest dose | 17.2 mg daily (label) | 2.4 mg weekly, or 7.2 mg (Wegovy HD, 2026) |
| Key trial | ATTAIN-1 (phase 3) | STEP 1 (phase 3) |
| Average weight loss | about 12% at 72 weeks (highest dose) | 14.9% at 68 weeks (2.4 mg weekly) |
| Placebo in that trial | about 1-2% | 2.4% |
Not a head-to-head comparison. The weight-loss numbers come from separate trials with different people, doses and lengths. A direct trial is the only way to know which works better.
How they differ
Orforglipron works on glp-1 only (small molecule, not a peptide); Semaglutide works on glp-1 only. Orforglipron is taken as: tablet, once daily (foundayo).Semaglutide is taken as: injection weekly (ozempic, wegovy) or daily tablet.
Dose schedules and warnings: Orforglipron dosage chart ยท Semaglutide dosage chart.
Questions
- Is orforglipron stronger than semaglutide?
- No trial has compared them directly. In separate trials, Orforglipron averaged about 12% weight loss (ATTAIN-1 (phase 3), 72 weeks) and Semaglutide 14.9% (STEP 1 (phase 3), 68 weeks). Different trials enroll different people over different lengths of time, so the numbers are not a fair head-to-head comparison.
- Is orforglipron FDA-approved?
- FDA-approved April 2026 (weight).
- Is semaglutide FDA-approved?
- FDA-approved (2017 diabetes, 2021 weight).
Sources
- Healio: FDA approves orforglipron, an oral GLP-1, for adults with obesity (Apr 2026)
- Wilding et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021
Last checked 2026-11-16. How we pick and check sources: methodology.